The risk assessments pursuant to Article 11 of Implementing Regulation (EU) No 844/2012 for 1-naphthylacetamide, 1-naphthylacetic acid, esfenvalerate, fluazifop-P, pyridaben and spiroxamine have not yet been finalised by the rapporteur Member States and additional time is required to complete the remaining steps in each renewal procedure.
Recital 40, Regulation (EU) 2026/372
In forcesince 20 Feb 2026
- celex=32012R0844